The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future
The ever-increasing burden of type 2 diabetes mellitus (T2DM) worldwide, has led to the emergence of several antidiabetes drugs with different modes of action. Incretin hormones and their effect on glucose metabolism and pathogenesis of T2DM has been a landmark discovery in the management of this in...
Guardado en:
Autor principal: | Juris J. Meier |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3f80af6f0ce043bc92ebdb42b6a1472a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
por: Ekaterina Alekseevna Shestakova
Publicado: (2011) -
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
por: Enrique Z. Fisman, et al.
Publicado: (2021) -
Incretin-based therapy: renal effects
por: Anton Ivanovich Korbut, et al.
Publicado: (2016) -
Incretins today: multiple effects and therapeutic potential
por: Oksana V. Tsygankova, et al.
Publicado: (2019) -
Vildagliptin: optimal control in type 2 diabetes mellitus treatment
por: Alexander Sergeevich Ametov
Publicado: (2015)